Product Image

Glucose Stabili-T

LifeSeasons
4.6
★ ★ ★ ★ ★
(604 ratings)
Chromium 800 mcg
Vanadium 200 mcg
Fenugreek 500 mg
Product Image
Score67
Broad, partly standardized glucose-support ingredients provide useful metabolic depth. High cost, formula complexity, and low-blood-sugar interaction risk limit suitability.
How scoring works
Quantity:90 Capsule(s) • (30 servings)
Goals:
Metabolism Boost
Weight Loss

Score 67

Broad, partly standardized glucose-support ingredients provide useful metabolic depth. High cost, formula complexity, and low-blood-sugar interaction risk limit suitability.
How scoring works
$42.99($1.43 per serving)
Pure Formulas
$ 42.99
iHerb
$ 42.99
Report prices

Analysis

Fenugreek at 500 mg and gymnema at 400 mg create the main botanical base, supported by chromium at 800 mcg. Bitter melon, banaba, holy basil, cinnamon, and alpha-lipoic acid add several glucose-related pathways.

Many extracts disclose active markers, which improves evaluation. The crowded formula still spreads the serving across numerous ingredients, and several secondary amounts are modest.

The capsules are better aligned with glucose management than direct weight loss or testosterone support. High cost and substantial interaction potential make casual experimentation less appealing.

Who is it for
  • Adults seeking multi-pathway glucose support
  • Users who can monitor blood sugar
  • People comfortable with a complex botanical formula
Best for
  • Glucose-metabolism support
  • Fenugreek and gymnema coverage
  • Standardized botanical intake

Pros

  • Meaningful fenugreek and gymnema amounts
  • High chromium amount
  • Several extracts disclose active markers
  • Fully lists ingredient weights

Cons

  • Very complex formula
  • Many secondary ingredients are modest
  • Premium serving cost
  • Weak direct testosterone relevance

Warnings

  • Chromium, vanadium, fenugreek, gymnema, bitter melon, and banaba may add to insulin or sulfonylurea effects and increase low-blood-sugar risk.
  • Fenugreek may cause gas, diarrhea, or allergic reactions in people sensitive to legumes.
  • Alpha-lipoic acid may further lower blood glucose and can cause nausea in sensitive users.

Nutrient quality

71 High impact

Several well-aligned metabolic ingredients reach meaningful amounts. Uneven standardization and additive glucose-lowering effects reduce confidence and safety.

.

Ingredient transparency

78 High impact

Individual active weights and several botanical markers are clearly listed. Full directions, inactive ingredients, and standardization for key extracts remain absent.

.

Customer satisfaction

65 High impact

The average customer rating is strong. The rating base is sufficient for moderate confidence in the average, while specific review experiences were not supplied.

.

Value for money

47 Lower impact

The coherent metabolic formula provides useful ingredient breadth. High serving cost and incomplete potency details make it uncompetitive.

.
Report analysis

Goals

Metabolism Boost
Impact
High effect
B Goal FitB Strength of SupportC+ CoverageC- Formula Quality

Chromium, fenugreek, gymnema, alpha lipoic acid, banaba, and bitter melon target glucose handling from several angles. The strongest ingredients and most amounts are individually disclosed.

Many secondary botanicals are modestly dosed, and vanadium has a narrow practical safety margin. Chromium, fenugreek, gymnema, banaba, bitter melon, and vanadium may add to glucose-lowering medication and increase the risk of low blood sugar.

Study evidence
Chromium Supportive 47 studies
Vanadium Supportive 7 studies
Weight Loss
Impact
Moderate effect
C Goal FitC+ Strength of SupportC- CoverageC Formula Quality

Chromium, fenugreek, gymnema, cinnamon, and related extracts provide broad support for glucose handling and craving control. The formula may be most relevant to people with impaired glucose regulation rather than as a general fat-loss product.

Chromium and major botanicals are disclosed at substantial amounts, but several secondary extracts are small and active standardization is incomplete. The combined glucose-lowering ingredients may amplify diabetes medicines and increase low-blood-sugar risk, so monitored users need medication-specific guidance.

Study evidence
Chromium No effect 24 studies

Ingredients

IngredientAmount per serving
Chromium (Chromium Niacinate)
800 mcg
Fenugreek seed extract
500 mg
Gymnema leaf extract (Gymnemic Acids)
400 mg
Cinnamon
90 mg
Bilberry fruit extract (Anthocyanins)
75 mg
Butcher's Broom root extract (Ruscogenins)
75 mg
Gotu Kola leaf extract (Triterpenes)
75 mg
Alpha Lipoic Acid
50 mg
Banaba leaf extract (Corsolic Acid)
50 mg
Bitter Melon fruit extract (Charantin)
50 mg
Holy Basil leaf extract (Oleanolic Acid, Ursolic Acid)
25 mg
Trace Minerals
25 mg
Vanadium (Vanadyl Sulfate)
200 mcg
Gluten Free Adults 18–50 Dairy Free Vegetarian
Report overview
B- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyA+ Value

A well-absorbed organic chromium form supports ingredient quality. The 800 mcg amount provides targeted potency, though the label gives only one weight rather than separating elemental chromium from compound weight. Standardized serving value is favorable for the delivered amount.

C- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

Vanadyl sulfate supplies a meaningful supplemental amount in a commonly researched form. The label identifies the vanadium dose clearly, though no manufacturing certification or independent purity testing is provided. The higher cost per serving and combination of chromium, fenugreek, gymnema, and bitter melon deserve caution for people using glucose-lowering medication because their effects may add together.

Fenugreek · 500 mg OverallScore41
F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyF Value

The fenugreek extract is supplied at a meaningful amount, but the label does not disclose a concentration ratio or active saponin content. Standard dry capsules provide no specific absorption support. The high serving cost and lack of extract standardization make it a weak fenugreek-specific value within this broad formula.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.
    Anderson RA; Cheng N; Bryden NA; Polansky MM; Cheng N; Chi J; Feng J · Diabetes · 1997
    Randomized trial180 participantsMetabolism Boost forChromium
  2. Improved meta-analytic methods show no effect of chromium supplements on fasting glucose.
    Bailey CH · Biological trace element research · 2014
    Meta-analysis809 participants16 studies pooledMetabolism Boost forChromium
  3. Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity.
    Masharani U; Gjerde C; McCoy S; Maddux BA; Hessler D; Goldfine ID; Youngren JF · BMC endocrine disorders · 2013
    Randomized trial31 participantsMetabolism Boost forChromium
  4. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Asemi Z · Annals of nutrition & metabolism · 2016
    Randomized trial64 participantsMetabolism Boost forChromium
  5. A Comprehensive insight into the effect of chromium supplementation on oxidative stress indices in diabetes mellitus: A systematic review.
    Kooshki F; Tutunchi H; Vajdi M; Karimi A; Niazkar HR; Shoorei H; Pourghassem Gargari B · Clinical and experimental pharmacology & physiology · 2024
    Systematic review33 studies pooledMetabolism Boost forChromium
  6. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis.
    Hu X; Wang W; Su X; Peng H; Tan Z; Li Y; Huang Y · PeerJ · 2023
    Meta-analysis2,362 participants41 studies pooledMetabolism Boost forChromium
  7. [Chromium supplementation in patients with type 2 diabetes and high risk of type 2 diabetes: a meta-analysis of randomized controlled trials].
    San Mauro-Martin I; Ruiz-León AM; Camina-Martín MA; Garicano-Vilar E; Collado-Yurrita L; Mateo-Silleras Bd; Redondo Del Río Mde P · Nutricion hospitalaria · 2017
    Meta-analysis13 studies pooledMetabolism Boost forChromium
  8. Insulin Receptor Substrates Regulation and Clinical Responses Following Vanadium-Enriched Yeast Supplementation in Obese Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Ghalichi F; Saghafi-Asl M; Kafil B; Faghfouri AH; Jourshari MR; Naserkiadeh AA; Ostadrahimi A · Biological trace element research · 2023
    Randomized trial44 participantsMetabolism Boost forVanadium
  9. Insulin signal mimicry as a mechanism for the insulin-like effects of vanadium.
    Mehdi MZ; Pandey SK; Théberge JF; Srivastava AK · Cell biochemistry and biophysics · 2006
    Narrative reviewMetabolism Boost forVanadium
  10. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies.
    Goldfine AB; Patti ME; Zuberi L; Goldstein BJ; LeBlanc R; Landaker EJ; Jiang ZY; Willsky GR; Kahn CR · Metabolism: clinical and experimental · 2000
    Clinical trial16 participantsMetabolism Boost forVanadium
  11. Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes.
    Cusi K; Cukier S; DeFronzo RA; Torres M; Puchulu FM; Redondo JC · The Journal of clinical endocrinology and metabolism · 2001
    Single-arm trial11 participantsMetabolism Boost forVanadium
  12. Effect of vanadium on insulin sensitivity in patients with impaired glucose tolerance.
    Jacques-Camarena O; González-Ortiz M; Martínez-Abundis E; López-Madrueño JF; Medina-Santillán R · Annals of nutrition & metabolism · 2009
    Randomized trial14 participantsMetabolism Boost forVanadium
  13. The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease.
    Farrokhian A; Mahmoodian M; Bahmani F; Amirani E; Shafabakhsh R; Asemi Z · Biological trace element research · 2021
    Randomized trial64 participantsWeight Loss forChromium
  14. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes.
    Martin J; Wang ZQ; Zhang XH; Wachtel D; Volaufova J; Matthews DE; Cefalu WT · Diabetes care · 2006
    Randomized trial37 participantsWeight Loss forChromium
  15. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial.
    Ashoush S; Abou-Gamrah A; Bayoumy H; Othman N · The journal of obstetrics and gynaecology research · 2017
    Randomized trial100 participantsWeight Loss forChromium
  16. Chromium supplementation and polycystic ovary syndrome: A systematic review and meta-analysis.
    Fazelian S; Rouhani MH; Bank SS; Amani R · Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2018
    Meta-analysis351 participants7 studies pooledWeight Loss forChromium
  17. Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.
    Kooshki F; Moradi F; Karimi A; Niazkar HR; Khoshbaten M; Maleki V; Pourghassem Gargari B · European journal of gastroenterology & hepatology · 2021
    Randomized trial46 participantsWeight Loss forChromium